![]() |
| [ На главную ] -- [ Список участников ] -- [ Правила форума ] -- [ Зарегистрироваться ] |
| On-line: |
| Клуб болельщиков "Торпедо" Владимир / / vrdIVVvyFV |
| Страницы: 1 |
|
| Автор | Сообщение |
|
Kirby Гость |
Добавлено: 19-07-2022 00:19 |
|
Where do you live? ibuprofen hexal He said the focus at Seattle Genetics remains expanding useof its lymphoma drug Adcetris. "Right now we are an emergingcompany ... we have a great trajectory in the future," Siegallsaid. "I believe that our big shareholders are supportive ofthat. I don't have any pressure on me to try to run out and dosome deal." |
| Страницы: 1 |
|
| Клуб болельщиков "Торпедо" Владимир / / vrdIVVvyFV |